Nuwellis (NUWE) Competitors $1.06 +0.07 (+6.57%) As of 12:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUWE vs. LFWD, VVOS, PSTV, XAIR, PETV, CODX, PAVM, ICU, ALUR, and SSKNShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), Plus Therapeutics (PSTV), Beyond Air (XAIR), PetVivo (PETV), Co-Diagnostics (CODX), PAVmed (PAVM), SeaStar Medical (ICU), Allurion Technologies (ALUR), and STRATA Skin Sciences (SSKN). These companies are all part of the "medical equipment" industry. Nuwellis vs. ReWalk Robotics Vivos Therapeutics Plus Therapeutics Beyond Air PetVivo Co-Diagnostics PAVmed SeaStar Medical Allurion Technologies STRATA Skin Sciences ReWalk Robotics (NASDAQ:LFWD) and Nuwellis (NASDAQ:NUWE) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking. Which has more risk & volatility, LFWD or NUWE? ReWalk Robotics has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Do institutionals & insiders have more ownership in LFWD or NUWE? 26.8% of ReWalk Robotics shares are held by institutional investors. Comparatively, 3.1% of Nuwellis shares are held by institutional investors. 2.5% of ReWalk Robotics shares are held by insiders. Comparatively, 2.6% of Nuwellis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is LFWD or NUWE more profitable? ReWalk Robotics has a net margin of -77.21% compared to Nuwellis' net margin of -169.54%. ReWalk Robotics' return on equity of -43.02% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets ReWalk Robotics-77.21% -43.02% -31.53% Nuwellis -169.54%-28,159.25%-207.24% Does the MarketBeat Community prefer LFWD or NUWE? Nuwellis received 11 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 53.66% of users gave Nuwellis an outperform vote. CompanyUnderperformOutperformReWalk RoboticsOutperform Votes11100.00% Underperform VotesNo VotesNuwellisOutperform Votes2253.66% Underperform Votes1946.34% Do analysts rate LFWD or NUWE? ReWalk Robotics presently has a consensus target price of $9.00, suggesting a potential upside of 547.95%. Nuwellis has a consensus target price of $17.00, suggesting a potential upside of 1,511.37%. Given Nuwellis' stronger consensus rating and higher possible upside, analysts clearly believe Nuwellis is more favorable than ReWalk Robotics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReWalk Robotics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has higher valuation and earnings, LFWD or NUWE? Nuwellis has lower revenue, but higher earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReWalk Robotics$25.66M0.58-$22.13M-$3.31-0.42Nuwellis$8.74M0.53-$20.21M-$38.53-0.03 Does the media favor LFWD or NUWE? In the previous week, ReWalk Robotics had 1 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for ReWalk Robotics and 2 mentions for Nuwellis. Nuwellis' average media sentiment score of 0.72 beat ReWalk Robotics' score of 0.47 indicating that Nuwellis is being referred to more favorably in the news media. Company Overall Sentiment ReWalk Robotics Neutral Nuwellis Positive SummaryReWalk Robotics beats Nuwellis on 11 of the 19 factors compared between the two stocks. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.62M$3.19B$5.49B$7.97BDividend YieldN/A1.80%5.11%4.23%P/E Ratio-0.0115.5122.6118.58Price / Sales0.5353.44397.51103.15Price / CashN/A44.0938.1834.62Price / Book0.063.526.704.26Net Income-$20.21M$94.03M$3.22B$248.31M7 Day Performance12.94%2.60%1.26%1.34%1 Month Performance10.13%5.73%3.73%3.92%1 Year Performance-77.34%-17.71%15.82%5.33% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis3.0504 of 5 stars$1.06+6.6%$17.00+1,511.4%-81.7%$4.62M$8.74M-0.0170Short Interest ↓Gap UpLFWDReWalk Robotics2.5499 of 5 stars$1.48-0.7%$9.00+508.1%-70.3%$15.73M$25.66M-0.5960VVOSVivos Therapeutics2.7893 of 5 stars$2.63-1.9%$6.10+131.9%+12.3%$15.43M$15.03M-0.46160Short Interest ↓Positive NewsGap DownPSTVPlus Therapeutics2.5814 of 5 stars$0.82-3.1%$11.50+1,305.9%-58.7%$14.08M$4.91M-0.3320XAIRBeyond Air4.4552 of 5 stars$0.20-0.5%$3.67+1,715.2%-82.0%$13.90M$3.02M-0.1970PETVPetVivoN/A$0.57+1.4%N/A-24.1%$13.75M$1.05M-1.2620CODXCo-Diagnostics4.324 of 5 stars$0.39+4.0%$5.50+1,324.9%-69.7%$12.96M$3.92M-0.28100Upcoming EarningsAnalyst ForecastNews CoverageGap UpPAVMPAVmed4.4111 of 5 stars$0.76+4.9%$19.50+2,482.8%-63.8%$12.91M$3.00M-0.1790Short Interest ↓Gap DownICUSeaStar Medical0.6473 of 5 stars$1.27flatN/A-89.3%$12.50M$135,000.00-0.112Short Interest ↓News CoverageALURAllurion Technologies3.4269 of 5 stars$2.36flat$22.83+867.5%-95.2%$11.31M$32.11M-0.20501Positive NewsGap DownSSKNSTRATA Skin Sciences3.513 of 5 stars$2.58-1.5%$6.00+132.6%-40.9%$10.76M$33.56M-0.97120Short Interest ↓Positive NewsGap Up Related Companies and Tools Related Companies LFWD Alternatives VVOS Alternatives PSTV Alternatives XAIR Alternatives PETV Alternatives CODX Alternatives PAVM Alternatives ICU Alternatives ALUR Alternatives SSKN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUWE) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NUWE Stock Free NUWE Stock Alerts